sulfonylurea vs glp 1 Adjusting Background Therapy when Initiating GLP-1 Receptor Agonists: What Pharmacists Need to Know (Module #2) Sulfonylureas in the Current Practice

This might all seem trivial, but a mere annoyance compounds when it must be repeated every week for the rest of your life

This happens primarily because of the weight loss spurred by these popular medications

Phentermine may interact with monoamine oxidase inhibitors (MAOIs)

The observed GLP-1R/GIPR dual activity is particularly similar to that of tirzepatide, a clinically approved dual incretin agonist (Jastreboff A et al., 2022)

The quality of life improvements - fewer hospitalizations, reduced overdoses, less suicidal ideation - represent genuine harm reduction beyond any metabolic benefits

From my own clinical experience, which could be skewed because I only serve people that don't get well in the traditional sector, but I would say 85 percent of people are walking around either with a diagnosed thyroid condition and being inappropriately managed or walking around being told they do not have a thyroid condition when they actually do